Ok_老虎社区_美港股上老虎

RiveR
2021-08-10

II-VI Stock Falls After Q4 Results, Notes Gross Margin Pressure<blockquote>II-VI股票在第四季度业绩公布后下跌，指出毛利率压力</blockquote>

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":896778288,"tweetId":"896778288","gmtCreate":1628607811844,"gmtModify":1631889576706,"author":{"id":3575101457760136,"idStr":"3575101457760136","authorId":3575101457760136,"authorIdStr":"3575101457760136","name":"RiveR","avatar":"https://static.tigerbbs.com/538b9774728e7d20268bfed68efcb02e","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":2,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Ok</p></body></html>","htmlText":"<html><head></head><body><p>Ok</p></body></html>","text":"Ok","highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/896778288","repostId":2158477942,"repostType":4,"repost":{"id":"2158477942","kind":"highlight","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1628607286,"share":"https://www.laohu8.com/m/news/2158477942?lang=zh_CN&edition=full","pubTime":"2021-08-10 22:54","market":"us","language":"en","title":"II-VI Stock Falls After Q4 Results, Notes Gross Margin Pressure<blockquote>II-VI股票在第四季度业绩公布后下跌，指出毛利率压力</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2158477942","media":"Benzinga","summary":"\n","content":"<p><ul>  <li><b><a href=\"https://laohu8.com/S/IIVI\">II-VI Inc</a></b>&nbsp;(NASDAQ:IIVI)&nbsp;reported fourth-quarter&nbsp;FY21 revenue growth of 8.3% year-on-year to $808 million, beating the analyst consensus of $783.33 million.</li>  <li><b>Segments:&nbsp;</b>Photonic Solutions revenue increased 6.3% Y/Y to $549.7 million. Revenue from Compound Semiconductors rose 12.8% Y/Y to $258.3 million.</li>  <li><b>Margins:&nbsp;</b>The non-GAAP gross margin contracted 370 bps to 38.6% as the costs rose 12.7% Y/Y.</li>  <li>The non-GAAP operating margin expanded 170 bps to 18.4% as the expenses declined 18% Y/Y.</li>  <li>Non-GAAP operating margin for Compound Semiconductors expanded 810 bps to 23.7%, while contracted 130 bps to 15.9% for Photonic Solutions segment.</li>  <li>Non-GAAP EPS of $0.88 beat the analyst consensus of $0.76.</li>  <li>II-VI held $1.6 billion in cash and equivalents as of June 30, 2021, and generated $574.4 million in operating cash flow during FY21.</li>  <li>The Q4 revenue exceeded the top end of II-VI's guidance with a book-to-bill ratio of 1.14.</li>  <li>In communications, FY21 revenue improved 11%, driven by 100, 200, 400G datacom transceivers and coherent optics.</li>  <li>II-VI's life sciences revenue grew by 65% Y/Y in support of COVID and other diagnostic testing.</li>  <li>II-VI expects the pending acquisition of&nbsp;<b><a href=\"https://laohu8.com/S/COHR\">Coherent</a> Inc&nbsp;</b>(NASDAQ:COHR)<b>&nbsp;</b>to close during the first calendar quarter of 2022.</li>  <li><b>Outlook:&nbsp;</b>II-VI sees Q1 FY22 revenue of $780 million - $830 million compared to the analyst consensus of $804.04 million.</li>  <li>It forecasts a non-GAAP EPS of $0.75 - $0.90 versus the analyst consensus of $0.90.</li>  <li><b>Price action:</b>&nbsp;IIVI shares traded lower by 5.30% at $64.26 on the last check Tuesday.</li> </ul></p><p><blockquote><ul><li><b><a href=\"https://laohu8.com/S/IIVI\">II-VI公司</a></b>（纳斯达克股票代码：IIVI）公布21财年第四季度收入同比增长8.3%至8.08亿美元，超出分析师预期的7.8333亿美元。</li><li><b>区段：</b>Photonic Solutions收入同比增长6.3%至5.497亿美元。化合物半导体收入同比增长12.8%至2.583亿美元。</li><li><b>利润：</b>由于成本同比增长12.7%，非GAAP毛利率收缩370个基点至38.6%。</li><li>由于费用同比下降18%，非GAAP营业利润率扩大170个基点至18.4%。</li><li>化合物半导体的非GAAP营业利润率增长810个基点至23.7%，而光子解决方案部门的营业利润率收缩130个基点至15.9%。</li><li>非GAAP每股收益为0.88美元，超过分析师预期的0.76美元。</li><li>截至2021年6月30日，II-VI持有16亿美元现金及等价物，并在2021财年产生了5.744亿美元的运营现金流。</li><li>第四季度收入超过了II-VI指导的上限，订单出货率为1.14。</li><li>在通信领域，在100、200、400G数据通信收发器和相干光学器件的推动下，2021财年收入增长了11%。</li><li>II-VI的生命科学收入同比增长65%，以支持COVID和其他诊断测试。</li><li>II-VI预计待收购<b><a href=\"https://laohu8.com/S/COHR\">一致的</a>Inc</b>（纳斯达克：COHR）<b> </b>将于2022年第一季度关闭。</li><li><b>展望：</b>II-VI预计2022财年第一季度收入为7.8亿至8.3亿美元，而分析师普遍预期为8.0404亿美元。</li><li>它预测非GAAP每股收益为0.75-0.90美元，而分析师普遍预期为0.90美元。</li><li><b>价格走势：</b>周二最后一次检查时，IIVI股价下跌5.30%，至64.26美元。</li></ul></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>II-VI Stock Falls After Q4 Results, Notes Gross Margin Pressure<blockquote>II-VI股票在第四季度业绩公布后下跌，指出毛利率压力</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nII-VI Stock Falls After Q4 Results, Notes Gross Margin Pressure<blockquote>II-VI股票在第四季度业绩公布后下跌，指出毛利率压力</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time smaller\">2021-08-10 22:54</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p><ul>  <li><b><a href=\"https://laohu8.com/S/IIVI\">II-VI Inc</a></b>&nbsp;(NASDAQ:IIVI)&nbsp;reported fourth-quarter&nbsp;FY21 revenue growth of 8.3% year-on-year to $808 million, beating the analyst consensus of $783.33 million.</li>  <li><b>Segments:&nbsp;</b>Photonic Solutions revenue increased 6.3% Y/Y to $549.7 million. Revenue from Compound Semiconductors rose 12.8% Y/Y to $258.3 million.</li>  <li><b>Margins:&nbsp;</b>The non-GAAP gross margin contracted 370 bps to 38.6% as the costs rose 12.7% Y/Y.</li>  <li>The non-GAAP operating margin expanded 170 bps to 18.4% as the expenses declined 18% Y/Y.</li>  <li>Non-GAAP operating margin for Compound Semiconductors expanded 810 bps to 23.7%, while contracted 130 bps to 15.9% for Photonic Solutions segment.</li>  <li>Non-GAAP EPS of $0.88 beat the analyst consensus of $0.76.</li>  <li>II-VI held $1.6 billion in cash and equivalents as of June 30, 2021, and generated $574.4 million in operating cash flow during FY21.</li>  <li>The Q4 revenue exceeded the top end of II-VI's guidance with a book-to-bill ratio of 1.14.</li>  <li>In communications, FY21 revenue improved 11%, driven by 100, 200, 400G datacom transceivers and coherent optics.</li>  <li>II-VI's life sciences revenue grew by 65% Y/Y in support of COVID and other diagnostic testing.</li>  <li>II-VI expects the pending acquisition of&nbsp;<b><a href=\"https://laohu8.com/S/COHR\">Coherent</a> Inc&nbsp;</b>(NASDAQ:COHR)<b>&nbsp;</b>to close during the first calendar quarter of 2022.</li>  <li><b>Outlook:&nbsp;</b>II-VI sees Q1 FY22 revenue of $780 million - $830 million compared to the analyst consensus of $804.04 million.</li>  <li>It forecasts a non-GAAP EPS of $0.75 - $0.90 versus the analyst consensus of $0.90.</li>  <li><b>Price action:</b>&nbsp;IIVI shares traded lower by 5.30% at $64.26 on the last check Tuesday.</li> </ul></p><p><blockquote><ul><li><b><a href=\"https://laohu8.com/S/IIVI\">II-VI公司</a></b>（纳斯达克股票代码：IIVI）公布21财年第四季度收入同比增长8.3%至8.08亿美元，超出分析师预期的7.8333亿美元。</li><li><b>区段：</b>Photonic Solutions收入同比增长6.3%至5.497亿美元。化合物半导体收入同比增长12.8%至2.583亿美元。</li><li><b>利润：</b>由于成本同比增长12.7%，非GAAP毛利率收缩370个基点至38.6%。</li><li>由于费用同比下降18%，非GAAP营业利润率扩大170个基点至18.4%。</li><li>化合物半导体的非GAAP营业利润率增长810个基点至23.7%，而光子解决方案部门的营业利润率收缩130个基点至15.9%。</li><li>非GAAP每股收益为0.88美元，超过分析师预期的0.76美元。</li><li>截至2021年6月30日，II-VI持有16亿美元现金及等价物，并在2021财年产生了5.744亿美元的运营现金流。</li><li>第四季度收入超过了II-VI指导的上限，订单出货率为1.14。</li><li>在通信领域，在100、200、400G数据通信收发器和相干光学器件的推动下，2021财年收入增长了11%。</li><li>II-VI的生命科学收入同比增长65%，以支持COVID和其他诊断测试。</li><li>II-VI预计待收购<b><a href=\"https://laohu8.com/S/COHR\">一致的</a>Inc</b>（纳斯达克：COHR）<b> </b>将于2022年第一季度关闭。</li><li><b>展望：</b>II-VI预计2022财年第一季度收入为7.8亿至8.3亿美元，而分析师普遍预期为8.0404亿美元。</li><li>它预测非GAAP每股收益为0.75-0.90美元，而分析师普遍预期为0.90美元。</li><li><b>价格走势：</b>周二最后一次检查时，IIVI股价下跌5.30%，至64.26美元。</li></ul></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"COHR":"COHERENT","IIVI":"COHERENT CORP 6.00% MANDATORY CON PFD SER A"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2158477942","content_text":"II-VI Inc (NASDAQ:IIVI) reported fourth-quarter FY21 revenue growth of 8.3% year-on-year to $808 million, beating the analyst consensus of $783.33 million.\nSegments: Photonic Solutions revenue increased 6.3% Y/Y to $549.7 million. Revenue from Compound Semiconductors rose 12.8% Y/Y to $258.3 million.\nMargins: The non-GAAP gross margin contracted 370 bps to 38.6% as the costs rose 12.7% Y/Y.\nThe non-GAAP operating margin expanded 170 bps to 18.4% as the expenses declined 18% Y/Y.\nNon-GAAP operating margin for Compound Semiconductors expanded 810 bps to 23.7%, while contracted 130 bps to 15.9% for Photonic Solutions segment.\nNon-GAAP EPS of $0.88 beat the analyst consensus of $0.76.\nII-VI held $1.6 billion in cash and equivalents as of June 30, 2021, and generated $574.4 million in operating cash flow during FY21.\nThe Q4 revenue exceeded the top end of II-VI's guidance with a book-to-bill ratio of 1.14.\nIn communications, FY21 revenue improved 11%, driven by 100, 200, 400G datacom transceivers and coherent optics.\nII-VI's life sciences revenue grew by 65% Y/Y in support of COVID and other diagnostic testing.\nII-VI expects the pending acquisition of Coherent Inc (NASDAQ:COHR) to close during the first calendar quarter of 2022.\nOutlook: II-VI sees Q1 FY22 revenue of $780 million - $830 million compared to the analyst consensus of $804.04 million.\nIt forecasts a non-GAAP EPS of $0.75 - $0.90 versus the analyst consensus of $0.90.\nPrice action: IIVI shares traded lower by 5.30% at $64.26 on the last check Tuesday.","news_type":1,"symbols_score_info":{"COHR":0.9,"IIVI":0.9}},"isVote":1,"tweetType":1,"viewCount":2552,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":2,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}